Article
New-Born Screening for Spinal Muscular Atrophy: Results of a Latvian Pilot Study
14 Feb 2022
Abstract excerpt
New disease-modifying treatments have recently been approved for 5q spinal muscular atrophy (SMA) and early treatment has been associated with a better clinical outcome. Accordingly, new-born screening (NBS) for SMA should be implemented to ensure early diagnosis of affected individuals. The aim of this study was to determine the feasibility and usefulness of NBS for SMA in Latvia. Between February and November...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
